# Impact of AIT on Allergic Rhinitis and Asthma

> **NCT04125888** · — · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 92048 (actual)

## Conditions studied

- Allergy
- Respiratory Disease

## Interventions

- **DRUG:** Allergy immunotherapy (AIT)

## Key facts

- **NCT ID:** NCT04125888
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2021-04-16
- **Final completion:** 2021-04-16
- **Target enrollment:** 92048 (ACTUAL)
- **Last updated:** 2021-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04125888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04125888, "Impact of AIT on Allergic Rhinitis and Asthma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04125888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*